Drug · DIN 02449498
GENVOYA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since February 3, 2016; first marketed February 3, 2016.
- Drug Identification Number (DIN)
- 02449498
- Company (DIN owner)
- Gilead Sciences Canada IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat J05AR18
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ELVITEGRAVIR | 150 MG | |
| COBICISTAT | 150 MG | |
| EMTRICITABINE | 200 MG | |
| TENOFOVIR ALAFENAMIDE (TENOFOVIR ALAFENAMIDE HEMIFUMARATE) | 10 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 27, 2015: NOC 17522New Drug Submission (NDS)